Treatment preferences of adolescent patients with asthma

Pediatric Allergy and Immunology

Volumn 11, Issue 1, 2000, Pages 49-55

  Weinberg, Eugene G ^a   Naya, Ian ^b  

^a RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Adolescent; Asthma; Beclomethasone; Corticosteroid inhaler; Leukotriene receptor antagonist; Oral therapy; Preference; Zafirlukast

Indexed keywords

BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE; ZAFIRLUKAST;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CZECH REPUBLIC; DRUG TOLERANCE; FEMALE; FINLAND; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PATIENT COMPLIANCE; PHARYNGITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOUTH AFRICA; TECHNIQUE; UNITED KINGDOM;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; CHILD; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUESTIONNAIRES; TABLETS; TOSYL COMPOUNDS;

EID: 0034067688     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2000.00043.x     Document Type: Article

References (23)

1. BURR ML. Epidemiology of clinical allergy. Monogr Allergy 1993: 31: 80-102.
2. ANDERSON HR, BUTLAND BK, STRACHAN DP. Trends in prevalence and severity of childhood asthma. BMJ 1994: 308: 1600-4.
3. KAUR B, ANDERSON HR, AUSTIN J, et al. Prevalence of asthma symptoms, diagnosis, and treatment in 12-14 year old children across Great Britain (international study of asthma and allergies in childhood, ISAAC UK). BMJ 1998: 316: 118-24.
4. SIERSTED HC, BOLDSEN J, HANSEN HS, MOSTGAARD G, HYLDEBRANDT N. Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. BMJ 1998: 316: 651-5.
5. Office of Population Censuses and Surveys. England & Wales. Mortality Statistics. London: HMSO, 1993 DH2 (Suppl. 19): 38-9.
6. TAYLOR WR, NEWACHECK PW. Impact of childhood asthma on health. Pediatrics 1992: 90: 657-62.
7. KHUNTI K. Issues in adolescent asthma: compliance. Maternal Child Health 1996: February: 36-8
8. DOMPELING E, VAN GRUNSVEN PM, VAN SCHAYCK CP, FOLGERING H, MOLEMA J, VAN WEEL C. Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique. Fam Pract 1992: 9: 161-6.
9. MILGROM H, BENDER B, ACKERSON L, BOWRY P, SMITH B, RAND C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996: 98: 1051-7.
10. KELLOWAY JS, WYATT RA, ADLIS SA. Comparison of patients' compliance with prescribed oral inhaled asthma medications. Arch Intern Med 1994: 154: 1349-52.
11. FISH JE, KEMP JP, LOCKEY RF, GLASS M, HANBY LA, BONUCCELLI CM. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group. Clin Ther 1997: 19: 675-90.
12. SPECTOR SL, SMITH LJ, GLASS M. Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group. Am J Respir Crit Care Med 1994: 150: 618-23.
13. KNORR B, MATZ J, BERNSTEIN JA, et al. Montelukast for chronic asthma in 6-to 14-year-old children. A randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 1998: 279: 1181-6.
14. REISS TF, CHERVINSKY P, DOCKHORN RJ, SHINGO S, SEIDENBERG B, EDWARDS TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med 1998: 158: 1213-20.
15. NATHAN RA, BERNSTEIN JA, BIELORY L, et al. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol 1998: 102: 935-42.
16. TAYLOR D, TUNSTELL P. Metered dose inhalers: a system for assessing technique in patients and health professionals. Pharm J 1991: 239: 626-7.
17. BUIST AS. Pros and cons of oral anti-asthma medication. Eur Respir Rev 1995: 5: 158-60.
18. RIBEIRO LB, WIRÉN JE. Comparison of Bricanyl Turbohaler and Berotec dry powder inhaler. Allergy 1990: 45: 382-5.
19. RINGDAL N, WHITNEY JG, SUMMERTON L. Problems with inhaler technique and patient preference for oral therapy - tablet zafirlukast vs inhaled beclomethasone [Abstract]. Eur Respir J 1997: 10: 437S.
20. RAND CS, WISE RA, NIDES M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 1992: 146: 1559-64.
21. LIM SH, GOH DYT, TAN AYS, LEE BW. Parents' perceptions towards their child's use of inhaled medications for asthma therapy. J Paediatr Child Health 1996: 32: 306-9.
22. FABBRI LM, PIATTELLA M, CARAMORI G, CIACCIA A. Oral vs inhaled asthma therapy. Pros, cons and combinations. Drugs 1996: 52 (Suppl. 6): 20-8.
23. PRICE J. The transition of management from childhood to adolescence. Eur Respir Rev 1997: 40: 19-23.